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Stroke is the second most frequent cause 
of death worldwide, a main cause of dis-
ability and a major cost factor for health 
care systems [1, 2, 3, 4]. Advances in stroke 
prevention and therapy have led to steadi-
ly falling incidence and mortality rates in 
high-income countries in recent decades 
[5, 6]. Nevertheless, due to demograph-
ic change, an increase in the total num-
ber of strokes is to be expected in many 
countries in the coming years [7, 8]. In 
this context, up-to-date epidemiological 
data on stroke and its temporal trends are 
an important basis for the estimation of 
the future burden of stroke and associated 
care needs within the population.
In Germany, too, stroke remains the 
second most frequent cause of death after 
coronary heart disease, despite the mor-
tality rate from stroke decreasing contin-
ually in the last few decades [9]. There 
are currently no up-to-date data available 
from Germany regarding temporal trends 
in stroke incidence. Therefore, it is un-
clear whether the positive trend in mor-
tality is caused mainly by declining inci-
dence, decreasing case fatality, or both. 
Data from other countries, however, sug-
gest that both trends are occurring at the 
same time [5, 10, 11].
In addition to incidence and mortali-
ty, the prevalence of stroke also has a high 
relevance for public health and health care 
planning, since it indicates the percent-
age of stroke survivors within the gener-
al population. Up to three quarters of all 
strokes are survived [12, 13] and the per-
sons affected must subsequently be pro-
vided with secondary preventive mea-
sures such as vascular surgery and spe-
cific medical therapies as well as with re-
habilitative or care services [14]. Current 
representative data from the first wave of 
the “German Health Interview and Ex-
amination Survey for Adults” (DEGS1) 
for people aged 40–70 years can be used 
to describe this population group. It is also 
possible to investigate the temporal trend 
in stroke prevalence for this age group in 
comparison with data from the German 
National Health Interview and Examina-
tion Survey 1998 (GNHIES98) [15].
This article presents the findings of 
DEGS1 regarding the lifetime prevalence 
of physician-diagnosed stroke in adults 
aged 40–79 years in Germany and ex-
amines trends in prevalence since GN-
HIES98.
Methods
Study design and sample
The“German Health Interview and Ex-




























Fig. 1 8 Lifetime prevalence of stroke in percent (95% confidence interval) according to sex and socio-
economic status, n=5,751
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part of the health monitoring programme 
at the Robert Koch Institute (RKI). The 
concept and design of DEGS are described 
in detail elsewhere [16, 17, 18, 19, 20]. The 
first data collection wave (DEGS1) was 
conducted from 2008 to 2011 and com-
prised interviews, examinations and tests 
[21, 22]. The target population was the 
resident population of Germany aged 
18–79 years. DEGS1 has a mixed design, 
which permits both cross-sectional and 
longitudinal analyses. For this purpose, 
a random sample from local population 
registries was drawn to supplement for-
mer participants of GNHIES98. A total of 
8,152 people participated, including 4,193 
first-time participants (response rate 42%) 
and 3,959 former participants of GN-
HIES98 (response rate 62%). In all, 7,238 
persons visited one of the 180 examina-
tion centres, and 914 were interviewed on-
ly. The net sample permits representative 
cross-sectional analyses for the age range 
of 18–79 years (n=7,988, including 7,116 in 
study centres) and time trend analyses in 
comparison with GNHIES98 to be carried 
out [17]. The analyses presented here refer 
to the sample of 5,901 people (3,110 wom-
en and 2,791 men) aged 40–79 years [17].
Variables
As part of a standardised, computer-as-
sisted, personal interview (CAPI) con-
ducted by a study physician, the follow-
ing question was asked in DEGS1 to es-
tablish whether a stroke had ever been di-
agnosed by a physician: “Has a doctor ev-
er diagnosed you as having a stroke?” In 
GNHIES98 it was asked analogously in a 
physician interview: “Has a doctor ever 
diagnosed the following illnesses or dis-
orders: stroke?”
Socioeconomic status was determined 
using an index that was based on infor-
mation on school and further education, 
vocational training, professional status 
and net household income (weighted by 
household needs) and which allows classi-
fication into either the low, middle or high 
status group [23].
Statistical analysis
The lifetime prevalence of stroke was cal-
culated as a percentage with 95% confi-
dence interval (95% CI) of the total num-
ber of participants with valid answers 
(“Yes” or “No”) to the question about ever-
diagnosed stroke. Participants with miss-
ing data or who answered “Don’t know” 
were excluded from the analyses.
The cross-sectional analyses on stroke 
prevalence in DEGS1 were carried out 
using a weighting factor, which corrects 
sample deviations from population struc-
ture (as of 31 December 2010) with re-
gard to age, sex, region and nationality, as 
well as type of community and education 
[17]. When calculating the weighting fac-
tor for former participants of GNHIES98, 
the probability of repeated participation, 
based on a logistic regression model, was 
taken into account. A non-response anal-
ysis and a comparison of selected indica-
tors with data from official statistics indi-
cate a high level of sample representative-
ness for the resident population of Ger-
many aged 18–79 years [17].
For the analysis of the temporal trend, 
stroke prevalence in DEGS1 was com-
pared with the prevalence in GNHIES98 
[15]. To this end, prevalence figures not 
yet available for GNHIES98 participants 
aged 40–79 years were calculated. In the 
course of this the GNHIES98 sample was 
adjusted to the population structure as of 
31 December 1997 by weighting the results 
for age, sex, region, nationality, commu-
nity type and education analogous to the 
weighting method in DEGS1 [17]. In or-
der to take into account the demograph-
ic changes in population structure since 
GNHIES98, in the second step of the 
trend analysis, the GNHIES98 data were 
age-adjusted to the population structure 
as of 31 December 2010.
In order to take into account both the 
weighting and the correlation of the par-
ticipants within sample points, the con-
fidence intervals were determined us-
ing survey procedures in Stata 12.1 and 
SAS 9.3 [24]. Differences were deemed 
to be statistically significant if the respec-
tive 95% confidence intervals of the prev-
alence estimates did not overlap.
Results
Data from the CAPI regarding physician-
diagnosed stroke were available for 5,842 
participants (99.0%) aged 40–79 years, of 
whom 3,073 were women and 2,769 men.
The lifetime prevalence of stroke in 
the age group 40–79 years overall is 2.9%. 
The prevalence is 2.5% in women and 
3.3% in men. In both sexes, as well as in 
total, prevalence increases continually 
with age: in women from 1.1% in the age 
group 40–49 years to 6.3% among persons 
70–79 years old; for men in the same age 
groups it increases from 0.7 to 8.1%, re-
spectively (. Tab. 1).
Both overall and in women and men 
separately, the lifetime prevalence of 
stroke is at its highest among people of 
low socioeconomic status and at its low-
est amongst those of high socioeconomic 
Tab. 1 Lifetime prevalence of stroke in adults aged 40–79 years in Germany in DEGS1 
(n=5,842) according to age group and sex
Age group in years 40–49 50–59 60–69 70–79 Overall
 % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
Women 1.1 (0.4–3.1) 0.8 (0.3–2.1) 3.1 (1.7–5.5) 6.3 (4.3–9.1) 2.5 (1.8–3,4)
Men 0.7 (0.3–1.7) 1.8 (1.0–3.4) 5.4 (3.6–8.0) 8.1 (5.5–11.9) 3.3 (2.6–4.2)
Overall 0.9 (0.4–1.8) 1.3 (0.8–2.2) 4.2 (3.0–5.9) 7.1 (5.2–9.7) 2.9 (2.3–3.6)
Tab. 2 Trends in lifetime prevalence of stroke over time in adults aged 40–79 years in Ger-





 % (95% CI) % (95% CI) % (95% CI) % (95% CI) % (95% CI)
Women 2.3 (1.7–3.2) 2.3 (1.7–3.2) 2.5 (1.8–3.4) +0.2 (−0.9; +1.2) +0.2 (−0.9; +1.2)
Men 2.4 (1.8–3.2) 2.8 (2.1–3.9) 3.3 (2.6–4.2) +0.9 (−0.1; +1.9) +0.5 (−0.6; +1.6)
Overall 2.4 (1.9–2.9) 2.6 (2.1–3.2) 2.9 (2.3–3.6) +0.5 (−0.2; +1.3) +0.3 (−0.5; +1.1)





status (. Fig. 1). This inverse social gra-
dient is more clearly pronounced amongst 
women than men and remains if age dif-
ferences between the status groups are 
controlled for in the statistical analysis.
. Tab. 2 compares lifetime prevalence 
of stroke in the age group 40–79 years 
in DEGS1 with those in GNHIES98. In 
GNHIES98, stroke prevalence in the 
age group 40–79 years, adjusted to the 
population structure as of 31 Decem-
ber 1997, was 2.4% (women, 2.3%; men, 
2.4%). After age-adjustment to the pop-
ulation structure as of 31 December 2010, 
the prevalence increased overall to 2.6% 
and to 2.8% amongst men. Given broad-
ly overlapping confidence intervals of the 
prevalence estimates, there are no statisti-
cally significant differences in stroke prev-
alence between GNHIES98 and DEGS1, 
either as a whole or in both sexes sepa-
rately.
Discussion
In view of the demographic change in 
Germany, up-to-date data on stroke prev-
alence and its trends are of major impor-
tance for the estimation of the future bur-
den of disease and associated care needs 
within the population. The analyses from 
DEGS1 presented here make an impor-
tant contribution towards this. Accord-
ing to these data, the lifetime prevalence 
of stroke among people aged 40–79 years 
in Germany is 2.9%. There is no clear ev-
idence for a change in the prevalence in 
this age group in the last 12 years.
Owing to the restriction to the 
40–79-year age group, the prevalence esti-
mate resulting from DEGS1 is not directly 
comparable with that of other studies. The 
median age at which a first stroke occurs 
is 73 years in Europe, with an interquartile 
range of 62–81 years [25]. This allows us 
to roughly estimate that up to two thirds 
of the cases in the total population may 
be recorded in the sample of 40–79 years 
investigated in DEGS1. Based on the da-
ta from the nationwide telephone health 
survey “German Health Update” (GE-
DA) 2009–2010 conducted by the Robert 
Koch Institute, stroke prevalence in adults 
aged 18 years and above—with no upper 
age limit—was estimated at 2.5% [26]. For 
the age group 40–79 years investigated in 
DEGS1, the prevalence in GEDA is similar 
to DEGS1 at 3.2% (95% CI 2.9–3.5).
However, time trends in stroke prev-
alence cannot be assessed using the GE-
DA results since no earlier data exist for 
this purpose. This gap is now closed by 
the DEGS1 results, even though the trend 
analysis is limited to the age group exam-
ined. Data from other countries show that 
stroke prevalence in the general popula-
tion aged 18 years and above is of compa-
rable magnitude—for example—in Eng-
land (2.3–2.4%) [27] and in the USA (2.6–
3.0%) [28]. In England, there was no rel-
evant change over time in recent years 
[27]. Trend analyses for the age group 40–
79 years investigated in DEGS1 are not 
available from other countries.
The lifetime prevalence of stroke in 
the population can remain constant over 
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Prevalence of stroke in adults aged 40–79 years in Germany.  
Results of the German Health Interview and 
Examination Survey for Adults (DEGS1)
Abstract
In the German Health Interview and Exam-
ination Survey (DEGS1), data on the preva-
lence of physician-diagnosed stroke were 
collected from 2008 to 2011 in a represen-
tative population-based sample of 5,901 
adults aged 40–79 years. The stroke preva-
lence in DEGS1 was compared with preva-
lence estimates from the German Nation-
al Health Interview and Examination Sur-
vey 1998 (GNHIES98). The lifetime prevalence 
of stroke in adults aged 40–79 years is 2.9% 
(women: 2.5%; men: 3.3%). In both sexes, 
the prevalence increases continuously with 
age, up to 6.3% in women and 8.1% in men 
70–79 years old. More pronounced in wom-
en than in men, the prevalence of stroke de-
creases with increasing socioeconomic sta-
tus. Compared to GNHIES98, there is no evi-
dence for a change in stroke prevalence over 
time. The prevalence of stroke in adults aged 
40–79 years in Germany is comparable to 
prevalence estimates from other national and 
international studies. Further studies should 
examine the reasons behind stable preva-
lence rates, accounting for population ageing 
and changes in incidence, mortality and case 
fatality rates.
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Prävalenz des Schlaganfalls bei Erwachsenen im Alter von 
40 bis 79 Jahren in Deutschland. Ergebnisse der Studie 
zur Gesundheit Erwachsener in Deutschland (DEGS1)
Zusammenfassung
In der Studie zur Gesundheit Erwachsener 
in Deutschland (DEGS1) wurden von 2008 
bis 2011 in einer bevölkerungsrepräsenta-
tiven Stichprobe von 5901 Personen im Al-
ter von 40 bis 79 Jahren Daten zur Prävalenz 
des ärztlich diagnostizierten Schlaganfalls er-
hoben. Die zeitliche Entwicklung der Schlag-
anfallprävalenz wurde durch einen Vergleich 
mit dem Bundes-Gesundheitssurvey 1998 
(BGS98) untersucht. Die Lebenszeitprävalenz 
des Schlaganfalls in der Altersgruppe von 40 
bis 79 Jahren beträgt insgesamt 2,9% (Frauen 
2,5%; Männer 3,3%). Bei beiden Geschlech-
tern steigt die Prävalenz mit zunehmen-
dem Alter kontinuierlich an, bis auf 6,3% bei 
Frauen und 8,1% bei Männern im Alter von 
70 bis 79 Jahren. Die Schlaganfallprävalenz 
sinkt mit steigendem Sozialstatus bei Frauen 
deutlicher als bei Männern. Im Vergleich mit 
dem BGS98 ergeben sich keine eindeutigen 
Hinweise auf eine Veränderung der Schlagan-
fallprävalenz im zeitlichen Verlauf. Die Ergeb-
nisse zur Schlaganfallprävalenz bei 40- bis 
79-Jährigen in Deutschland sind mit Präva-
lenzschätzungen aus anderen nationalen 
und internationalen Studien vergleichbar. Die 
Ursachen für gleichbleibende Prävalenzen 
sollten in ergänzenden Studien unter Berück-
sichtigung des demografischen Wandels und 
der Veränderungen von Inzidenz, Mortalität 
und Letalität untersucht werden.
Schlüsselwörter
Schlaganfall · Prävalenz · Trend ·  
Gesundheitssurvey · Bevölkerung
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time if incidence and mortality change 
to the same extent. Stroke mortality has 
been falling for some time in Germany 
[9]. On the other hand, no data are avail-
able with regard to trends in stroke inci-
dence in Germany. The number of hospi-
tal admissions for stroke could be used as 
a proxy for stroke incidence, since stroke 
patients in Germany are generally admit-
ted to hospital and treated as in-patients, 
and in recent years increasingly in stroke 
units in accordance with treatment guide-
lines [14, 29]. Data on the number of hos-
pitalizations for stroke are provided by of-
ficial hospitalization statistics. However, 
it must be noted that these statistics cap-
ture information on hospitalized cases, 
not on individual persons. Thus, a recur-
rent stroke in the same calendar year in 
the same person would lead to two cases 
of stroke hospitalization. Based on the da-
ta from hospitalization statistics, the num-
ber of hospitalized patients with a diag-
nosis of cerebrovascular disease (ICD10-
Codes I60-I69) fell by 9% overall from 
2000 to 2009, in women by 15% and in 
men by 1% [30]. This trend occurred in 
spite of demographic ageing, which in it-
self should have led to an increase in the 
number of hospitalizations (overall, +18%; 
women, +12%; men, +26%). On the other 
hand, without demographic ageing, num-
bers of hospitalizations would have fall-
en (overall, −23%; women, −24%; men, 
−22%) [30]. Therefore, differences in the 
development of hospitalizations between 
women and men resulted from the stron-
ger ageing effects amongst men.
Possibly the falling number of hospi-
talizations for stroke reflects the trend in 
incidence. In line with this, the drop in 
both incidence rates [5] and hospitaliza-
tions has been reported from other west-
ern countries [10, 11, 31]. In addition, the 
assumption of declining incidence rates is 
plausible in the light of falling mortality 
rates and lack of evidence for a change in 
prevalence.
Numerous studies from many coun-
tries have shown consistently that a lower 
socioeconomic status is associated with an 
increased stroke risk [32]. A possible ex-
planation for this inverse social gradient is 
the difference in the prevalence of vascu-
lar risk factors between the status groups, 
which is also found in cross-sectional 
analyses in DEGS1 [33]. Further popula-
tion-based incidence studies and longitu-
dinal studies are required in order to bet-
ter explain the complex inter-relationship 
between socioeconomic status and stroke 
[32].
Strengths and limitations
DEGS1 is a nationwide, population-repre-
sentative study, which permits generalisa-
tions with regard to stroke prevalence for 
the adult resident population of Germa-
ny aged 40–79 years. In further analyses 
using additional health information from 
DEGS1, it will be possible to draw con-
clusions concerning the influences of risk 
factors, consequences of illness and asso-
ciated utilisation of health care.
It should be noted that the data pre-
sented here are based on self-reports of 
participants regarding physician-diag-
nosed strokes. However, there is evidence 
from population-based studies that self-
reported diagnoses on stroke have a high 
validity [34, 35]. Furthermore, it must be 
assumed that people with severe function-
al impairment following a stroke are un-
derrepresented in the sample, especially if 
they live in care institutions. However, this 
probably affects only a very small percent-
age of people with stroke within the pop-
ulation, so that stroke prevalence will on-
ly be slightly underestimated. For exam-
ple, in an analysis of remuneration data 
from the “Gmünder Ersatzkasse” (a stat-
utory health insurance fund), only 3% of 
people with stroke received in-patient care 
in the first year following a stroke and only 
1% had the highest care level of 3 [36]. It is 
also known that severe strokes have a high 
case fatality, which means people who suf-
fer these less often become prevalent cas-
es. Nevertheless, because of the aforemen-
tioned selection, the prevalence estimates 
reported here are to be viewed overall as 
conservative.
The trend analysis between GNHIES98 
and DEGS1 may potentially be limited by 
technical differences between the studies 
in the way data were collected in the med-
ical interview (computer-assisted CAPI 
in DEGS1, record sheet with illnesses list-
ed in tabular form in GNHIES98). How-
ever, collection of information on stroke 
was standardised in both studies and in-
terviewers explicitly and specifically asked 
for physician-diagnosed strokes using 
very similar wordings. Thus, relevant in-
fluences through the technical implemen-
tation of data collection are unlikely. With 
regard to the trend analysis, it must also 
be mentioned that a small yet statistically 
significant difference between the surveys 
may be possibly overlooked because of the 
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